LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹1.90 Cr | ₹1.77 Cr | ₹8.95 Cr | ₹79 Cr | ₹8.81 Cr |
What is the latest Cash Flow from Operating Activities ratio of LYKA LABS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹1.90 Cr |
Mar2024 | ₹1.77 Cr |
Mar2023 | ₹8.95 Cr |
Mar2022 | ₹79 Cr |
Mar2021 | ₹8.81 Cr |
How is Cash Flow from Operating Activities of LYKA LABS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹1.90 Cr | 7.11 | |
Mar2024 | ₹1.77 Cr | -80.20 | |
Mar2023 | ₹8.95 Cr | -88.70 | |
Mar2022 | ₹79 Cr | 799.30 | |
Mar2021 | ₹8.81 Cr | - |
Compare Cash Flow from Operating Activities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹391.1 Cr | -3.6% | -4.7% | -3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -3.6% |
-4.7% |
-3% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses